FindMyKOL

Lisa Bomgaars, MD

Enriched profile

Baylor College of Medicine

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Houston, TX · South Central · United StatesSpecialtyHematology / OncologyFocusPharmaceutical studies and practices+4
Last active 2022FindMyKOL type: NationalLatest publication2022Online presenceverified 2026Payments2021–2022NIH funding1999–2008

Lisa Bomgaars is a Pharmaceutical studies and practices physician affiliated with Baylor College of Medicine. OpenAlex indexes 72 publications with 4,001 citations (h-index 30); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 26 Oct 2026

Overview

Updated 28 Oct 2026

Lisa Bomgaars, MD, is affiliated with Baylor College of Medicine. The public record shows 72 publications with 4,001 citations (h-index 30), centered on Pharmaceutical studies and practices, Venous Thromboembolism Diagnosis and Management, Blood Coagulation and Thrombosis Mechanisms. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 2 companies, 1 NIH-funded awards (1999–2008).

  • Most recent indexed publication: 2022 · Blood advances
  • Top research focus: Pharmaceutical studies and practices
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 2 companies

Generated from the cited public record · current as of 28 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Central Nervous System Neoplasms1 trialNervous System Neoplasms1 trialNeuro-Oncology / Glioma1 trialSarcoma1 trialGlioma1 trialAstrocytoma1 trialNeuroblastoma1 trialOligodendroglioma1 trialMedulloblastoma1 trialSarcoma, Ewing1 trialMeningioma1 trialRhabdomyosarcoma1 trialEpendymoma1 trialNeuroectodermal Tumors, Primitive, Peripheral1 trialComa1 trialCraniopharyngioma1 trialMyosarcoma1 trialNeoplasms, Germ Cell and Embryonal1 trialLeukemia (AML/ALL/CML/CLL)Atrial Fibrillation

Research focus

OpenAlex concept fingerprint
Pharmaceutical studies and practicesVenous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis MechanismsAcute Lymphoblastic Leukemia researchAtrial Fibrillation Management and Outcomes

Drugs & molecules

across trials, industry payments and publications
Pradaxageneric · Dabigatran etexilateClinical trials—Industry payments1Publications2Xareltogeneric · RivaroxabanClinical trials—Industry payments2Publications—

Works with

trial sponsors and companies reporting payments
Janssen Research & Development, LLCClinical trials—Industry payments2Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments1Children's Oncology GroupClinical trials1Industry payments—Texas Children's Cancer CenterClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
72publications

Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.

4,001citations

Total citations across indexed works.

30h-index

Hirsch index (OpenAlex). i10-index 45.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
2companies · 2021–2022

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 1999–2008

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 28 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 28 Oct 2026

2 companies reported payments to CMS in program years 2021–2022. These are public disclosures, not judgments. The latest:

NIH funding

Updated 28 Oct 2026

1 NIH research award on record, funded 1999–2008 per NIH RePORTER. The latest:

Congress activity

Updated 28 Oct 2026

6 congress contributions (2005–2023) across ASCO, ASH per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 28 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 28 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Susan M. Blaney18Stacey L. Berg15Manuela Albisetti13Igor S. Tartakovsky13Lesley Gayle Mitchell13Matteo Luciani13Martina Brueckmann12Leonardo Rodrigues Brandão12Elizabeth A. Chalmers12Fenglei Huang9Savion Gropper9Monika Simetzberger6Jun Teruya6Zhichao Sun6Ildar N. Nurmeev6Brady S. Moffett5Kirill V. Gorbatikov5Mark Krailo5Patrick A. Thompson5ZoAnn Eckert Dreyer4Mark L. Bernstein4Douglas S. Hawkins4Pavel Svirin4Jörg Kreuzer4Renee Klenke3Gary L. Rosner3Judy L. Felgenhauer3Branislav Biss3Anne‐Marie Langevin3Paola Saracco3Jacqueline Halton3Richard Greg Gorlick3RICHARD P. KADOTA3Anjali Alatkar Sharathkumar3Katherine A. Janeway3James Bruce Bussel3Donald L. Yee3Ha M. Dang3Olga A. Lvova3Kim Ritchey3

Online presence

Updated 28 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/lisa-bomgaars-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.